BRIEF published on 03/15/2024 at 19:30, 1 year 11 months ago Acnomel: A Dermatologist-Recommended Acne Solution Devoid of Cancer-Causing Agents Acnomel Skincare Acne Treatment Sulfur Safe Skincare Alternatives
BRIEF published on 03/15/2024 at 19:30, 1 year 11 months ago Acnomel : une solution contre l'acné recommandée par les dermatologues et dépourvue d'agents cancérigènes Acnomel Soins De La Peau Traitement De L'acnée Soufre Alternatives Sûres Aux Soins De La Peau
PRESS RELEASE published on 03/15/2024 at 19:25, 1 year 11 months ago Dermatologist Recommended Acnomel Offers Safe Alternative To Treat Acne Consumers seek safer acne treatments amid concerns over cancer-causing benzene in popular products. Acnomel tinted acne cream gains attention with proven efficacy and unique formulation Acnomel Acne Treatments Cancer-causing Benzene Safe Skincare Products DSE Healthcare Solutions
Published on 02/20/2026 at 18:30, 15 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 15 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 37 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 45 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 9 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 45 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 45 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 17 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 17 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
